Implementing Hospital Policies & Protocols

Similar documents
Inpatient Glycemic Management:

Special Situations 1

Meeting the Challenge of Inpatient Glycemic Management in the Non-Critical Care Setting

Learning Objectives. Perioperative SWEET Success

Improving Glycemic Control in the Critical Care

Disclosure 1/16/2017. Michael R. Brennan D.O., M.S., F.A.C.E Director Beaumont Endocrine Center Chief of Endocrine Beaumont Grosse Pointe 1/16/2017 2

Topics in Inpatient Glycemic Control

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI

In-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

LIBERTYHEALTH. Jersey City Medical Center Department of Patient Care Services. Approved by Policy Committee:

DIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0

Initiating Injectable Therapy in Type 2 Diabetes

Insulin Prior Authorization Criteria For Individuals who Purchased BlueCare / KS Solutions products

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

Pharmacy Plan Guidance

INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION

Insulin Prior Authorization with optional Quantity Limit Program Summary

Rebecca Newberry APRN MS CDE

HAP PA-HEN Achieving More Together

Advances in Diabetes Care Technologies

INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE

Managing Diabetes when you are having a colonoscopy

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

Insulin Prior Authorization Criteria For Individuals Who Purchased BlueCare/KS Solutions/EPO Products

In-hospital management of diabetes

DRUG ALLERGIES WT: KG

Hot Topics: The Future of Diabetes Management Cutting Edge Medication and Technology-Based Care

Diabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE

Poll Question 2. Special Boot Camp Workshop Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services.

DKA Adult ICU Powerplan

Basal Bolus Insulin Therapy Frequently Asked Questions

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors

Optimizing Care of the Inpatient with Hyperglycemia and Diabetes: Case Studies in Action

4/16/2018. Flexible Intensive Insulin Therapy (FIIT) in People with Type 2 Diabetes: A Viable Option. Disclosures. Outline. No financial disclosures

Type I Type II Insulin Resistance

Mixed Insulins Pick Me

APPENDIX American Diabetes Association. Published online at

Insulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology

ANNUAL MEETING 2 #FSHP2017

Newer Insulins. Boca Raton Regional Hospital 15th Annual Internal Medicine Conference

What s New in Type 2 Diabetes? 2018 Diabetes Updates

Technology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE

SHINE Study PowerChart Order Set CONTROL

Advances in Diabetes Care Technologies

Evidence for Basal Bolus Insulin Versus Slide Scale Insulin

Diabetic Emergencies DKA, HHS, Hypoglycemia. Disclosure. Learning Objectives

Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin

9/16/2013. No Conflict of Interest to Disclose

The ABCs of MDI: Gaining a working knowledge of Multiple Daily Injection insulin therapy. Today s Presenter

Managing Diabetes and Hyperglycemia Safely in the Complex Hospital Setting

Transforming Diabetes Care

Diabetes in Pregnancy

Nph insulin conversion to lantus

Collaborative Practice Agreement

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

Basics of Continuous Subcutaneous Insulin Infusion Therapy. Lubna Mirza, MD Norman Endocrinology Associates 2018

A Children s Bedtime Story

AACN PCCN Review. Endocrine

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies

DIABETES MEDICAL MANAGEMENT PLAN (DMMP) School Year: Student s Name: Date of Birth:

New Therapies for Diabetes Management: Hope or Headache?

Adjusting Insulin Doses

I. General Considerations

Diabetes Medical Management Plan

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions. Insulins. Rapid Short Intermediate Long Mix

8/13/2016. Insulin Basics. Rapid-Acting Insulin Analogs. Current Insulin Products and Pens. Basal Insulin Analogs. History of Insulin Therapy

Clinical Cases in Diabetes Management. Joseph Cook D.O.

Pumping Insulin is it for your patients?

Diabetes Medical Management Plan

Module 5. Understanding Insulin Therapy

Diabetes Devices Workshop Angela Aldrich, PharmD, PhC April Mott, PharmD, PhC, BCPS Presbyterian Medical Group 28 January 2018

Antihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014

Diabetic Ketoacidosis

Transition of Care in Hospitalized Patients with Hyperglycemia and Diabetes

Supplemental Health Record and Authorization for Care of Child with Insulin Dependent Diabetes

What s New in Type 2 Diabetes? 2018 Diabetes Updates

Insulin Regimens: Hitting Glycemia Targets

123 Are You Providing Evidence-Based Diabetes Care? - Martin

Management of Type 2 Diabetes Mellitus. Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism

Diabetes Update 10/12/2017. Section #1 OBJECTIVE. Lab features to consider:

2018 Diabetes Summit Managing Diabetes: An Art and a Science

HYPERGLYCEMIA MANAGEMENT PROTOCOL A BASAL/BOLUS REGIMEN. Kacy Aderhold, MSN, APRN-CNS, CMSRN

Inpatient Management of Diabetes Mellitus. Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy

Insulin Initiation and Intensification. Disclosure. Objectives

Glucose Management in the ICU: The Role of the Pharmacist

Pharmacology. Kacy Aderhold, MSN, APRN-CNS, CMSRN

TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

Type 2 Diabetes Mellitus Insulin Therapy 2012

Care of Students with Diabetes

Objectives. Navigating New Insulins. Disclosures. Diabetes: The Stats. Normal Insulin Release Individuals without diabetes. History of Insulin 5/23/17

DRUG ORDERING & DISPENSING:

Recent Advances in the Management of Diabetes

Providing Stability to an Unstable Disease

INSULIN 101: When, How and What

Tips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital

Care of Students with Diabetes

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE

[Insert School Logo] School Grade Teacher Physician Phone Fax Diabetes Educator Phone 504 Plan on file Yes No

Transcription:

Implementing Hospital Policies & Protocols Jane Jeffrie Seley DNP MPH GNP BC-ADM CDE CDTC FAADE FAAN Division of Endocrinology, Diabetes & Metabolism NewYork-Presbyterian Hospital Weill Cornell Medicine janeseley@nyp.org

Disclosures Jane Jeffrie Seley Advisory Panel: Boehringer-Ingelheim/Lilly Alliance Sanofi Diabetes Novonordis Abbott Nutrition Consultant: Johnson & Johnson Diabetes Institute Bayer Diabetes

Outline DKA Insulin Pumps Hypoglycemia Coordination of BG, Insulin & Meals Perioperative Care Nurses Role in Safe Insulin Administration

Adult DKA Guidelines at NYPH Insulin FS BG q 1 hour until BG < 250 mg/dl, stable & no change > 10 % for 3 hours, then FS BG q 2 hour - Serum Chemistry every 4 hours Regular Insulin: 0.15 Units/Kg as IV Bolus; Then IV infusion @ 0.1 Units/Kg/hr (100 Units/100 ml NS) If Serum Glucose does not fall by 50-70 mg/dl in the next hour: double Insulin Infusion every hour until Glucose Falls by 50-70 mg/dl

Adult DKA Guidelines at NYPH When Serum Glucose Reaches 250 mg/dl : Add Dextrose (D51 2NS or D5NS*) to IVF @ 150 250 ml/h to maintain serum glucose 150 200 mg/dl and continue insulin at same rate Titrate insulin to a minimum 0.1 Units/kg/hr and glucose goal between 150 200 mg/dl until ketosis and anion gap resolves. If patient can tolerate PO, encourage consistent carbohydrate diet * Use D5NS if corrected [Na+] 140 or remains volume depleted

Insulin Pumps Animas Ping/Vibe Insulet Omni Pod Medtronic 670G SAP Roche Accu-Chek Spirit Combo Tandem t:slim, t:slim G4, t:flex Valeritas V-Go

NYPH PATIENT S OWN INSULIN PUMP POLICY- ADULT Sample Nursing Documentation: Nursing Notes - Document the following: (1) Patient was admitted wearing insulin pump. (2) Assessment of insulin pump insertion site upon admission and every shift. (3) Site locations (4) When witnessing change in reservoir, infusion set, site and hospital insulin supplied (5) Episodes of hyper/hypoglycemia, pump and site problems and any interruptions in insulin delivery.

Insulin Pumps To stay on pump, patient must: Cognitively intact with fully functional pump and adequate supplies Able to demonstrate operational features pump Clinician who is knowledgeable about insulin pumps should follow patients on own pump and make dose adjustments

Insulin Pumps (Cont.) Order set for patient s own pump should include: Order patient may use own insulin pump Order for insulin vial for pump Patient s signed consent??? Flow sheet for patient to document all basal settings, boluses, site changes

Patient s Own Insulin Pump: Competency Must Be Evaluated Vs. Safety Issues Patient s Own Glucose Meter? Patient s Own Insulin? Drip vs. Pump in ICU? Nursing Documentation

Hypoglycemia Treatments

Delineate Treatment Options If patient is eating and able to swallow: one tube glucose gel OR 4 oz fruit juice (apple preferred) If patient cannot swallow or is NPO, Unconscious or NOT alert: -If IV access Give D50W 50 ml IV Push -If no IV access Give Glucagon injection IM -May repeat glucagon x 1 only in 15 mins Glucose gel & D50W in Automated Dispensing Cabinet (ADC) as over-ride, glucagon in crash cart

Coordination of BG, Insulin & Meals

Controlled Carbohydrate Meal Plan Controlled CHO meal plan recommended for patients with diabetes and/or hyperglycemia CHO are counted but # may vary from tray to tray Offers more flexibility & choices Should not restrict calories in acutely ill patients Snacks: Not necessary with basal insulin & appropriate insulin dosing

Coordinating Meals, BGM & Insulin Timing is Everything: What Goes Wrong Meal tray delivery times vary from the kitchen BGM done too soon before mealtime Poor communication between person checking BG and RN administering insulin Tray delivered to room without BG or insulin BG checked after patient started meal Room service delivers meals directly to pt without notification or coordination with nursing

Meal Comparison at 3 Sites Meal Options UCSD San Diego VMMC Seattle NYPH New York Carb controlled diet All carb limited trays limited to 60g per tray, including room service All carbs labelled on the menu, no restrictions, room service 45 g/tray 60 g/tray- default 75 g/tray Alert Trays Arriving Phone call from kitchen 30 min prior to tray arrival on floor BG Check Trays delivered by Nutritional Insulin administration Done by RN 30 min prior to scheduled meal-time with call from kitchen as reminder Food Service staff leaves all carb limited trays in cart to be delivered by RN (with insulin). Room service has cut-offs when patient allowed to order/receive carb limited tray Administered with first bite of food or up to 30 min after if patient has nausea or poor appetite Kitchen staff notifies RN by Vocera Patient presses call light when they order and then patient care technician comes to check BG Delivered by patient care technician or RN With first bite of food Tray assistant notifies RN upon tray arrival on unit Done by RN within 60 minutes of arrival of tray on unit Food Service staff delivers carb controlled trays first directly to patient +/- 15 min of first bite of food

PERIOPERATIVE Glycemic Control

Perioperative Glycemic Control Perioperative hyperglycemia matters: Malglycemia causes oxidative stress Increased risk of inflammation & infection Increased risk of thrombosis Post-op period matters: > infections, arrhythmias, renal impairment Studies show improving glycemic control reduces risk of complications Akhtar Anesth Analg (2010), Diabetes Care (2009), Whitcomb et.al (2005), Freire et. al (2005), Zerr KJ, et al (1997)

Standards of Care Obtain A1c pre-op for pts with diabetes or DM risk factors, make regimen adjustments prior to surgery Use intravenous insulin drip in pts who take insulin PTA & are undergoing major surgical procedures, with known target e.g. BG 120-180 mg/dl Use subcutaneous (subq) correction dose or insulin drip during minor or short surgical procedures, with target BG 140-180 mg/dl, and monitor BG q1 2 hours, depending on insulin used and type of surgery.

AACE / ADA guidelines for Perioperative Care: American College of Phyisicians (PIER): Society for Ambulatory Anesthesia Guidelines on Perioperative Management of the Adult Patient with Diabetes. Standards of Care (Cont.) Anesthesia and OR team should make sure: BG levels are monitored at least every hour for patients on insulin drip If using insulin during surgery, potassium levels are measured every 4 to 6 hours in OR BG is monitored in the recovery room immediately after surgery and ongoing if needed

Peri-Op Patient Education Medications to take the day before surgery Medications to take the morning of surgery Medications to take post op in hospital or at home How will patient get this information?

DIABETES MEDICATION ADJUSTMENTS PRIOR TO PROCEDURE AND SURGERY

Medications Oral sulfonylureas: Glyburide (Micronase ), glipizide(glucotrol ), glimepiride (Amaryl ) Sodium-Glucose Co-Transporter 2 Inhibitor (SGLT-2): canagliflozin (Invokana ), dapagliflozin (Farxiga ), empagliflozin (Jardiance ) Day Before Procedure or Surgery Take only morning and/or lunch doses Stop taking any medications including combinations containing SGLT-2s 3-5 days before surgery or procedure Day of Procedure or Surgery None None All other oral agents Take usual dose(s) None Non-insulin injectables: GLP-1 RAs, Daily: Take usual dose None pramlintide (Symlin ) Weekly: Hold if dose within 3 Rapid/Short acting insulins: Regular (Humulin R, Novolin R), Lispro (Humalog ), Aspart (Novolog ), Glulisine (Apidra ) Insulin NPH Humulin N, Novolin N days Before meals: Take usual dose No bedtime dose Morning dose: Take usual dose Dinner/bedtime dose: T1DM: Reduce dose by 20% T2DM: Reduce dose by 30% None T1DM: Reduce dose by 30% T2DM: Reduce dose by 50%

Medications Long-acting basal insulin U100 glargine (Lantus ), U100 detemir (Levemir ), Longer-acting basal insulin U300 glargine (Toujeo ), U100 & U200 degludec (Tresiba ) Day Before Procedure or Surgery Long-acting basal: Morning dose: Take 100% Dinner/bedtime dose: reduce by 20% Longer-acting basal: Reduce AM and/or PM dose by 20% Day of Procedure or Surgery T1DM: Reduce dose by 20% T2DM: Reduce dose by 50% Pre-Mixed Insulin Humulin 70/30, Novolin 70/30, Novolog Mix 70/30, Humalog Mix 75/25 Morning Dose: Take 100% T1DM: Reduce dinner dose by 20% T2DM: Reduce dinner dose by 30% T1DM: Reduce dose by 50% T2DM: Do not take Insulin Pumps Ask patient to contact PCP/endocrinologist for orders, or reduce all basal rates by 20% for outpatients. Endocrine/Maternal Fetal Medicine consult mandatory for all inpatients

The Role of the RN in Safe & Effective Insulin Administration

Role of the RN in Safe & Effective Insulin Administration RN should report BG <100 or >180 mg/dl to primary team for insulin adjustment Primary team should reduce insulin dose when BG is <100 or >180 mg/dl RN should never hold or change insulin dose without consulting primary team, that is prescribing & out of scope of practice of RN in NYS NO ONE should hold basal insulin in a patient with type I diabetes, including when pt is NPO

Key Glycemic Control References American Diabetes Association: Standards of medical care in diabetes 2017. Diabetes care in the hospital. Diabetes Care. 2017;40(Suppl. 1):104 S109. Draznin, B. et al. Pathways to quality inpatient management of hyperglycemia and diabetes: A call to action. Diabetes Care. 2013;36:1807-14. Rodriguez, A., et al. Best practices for interdisciplinary care management by hospital glycemic teams: Results of a society of hospital medicine survey among 19 U.S. hospitals. Diabetes Spectrum. 2014;27:197-205. Rushakoff, R.J., et al. Using a mentoring approach to implement an inpatient glycemic control program in United States hospitals. Healthcare. 2014:2;205-210. Umpierrez, G.E., et al. Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2012;97:16 38.

29